AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Perindopril Erbumine in South Africa
5 products registered with SAHPRA — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| CIPLA PERINDOPRIL 8 mg | 41/7.1.3/0675 | Cipla Medpro (Pty) Ltd | suspended | 20 Apr 2026 |
| CIPLASYL 2 | 41/7.1.3/0670 | Cipla Medpro (Pty) Ltd | suspended | 18 Jul 2025 |
| CIPLASYL 4 | 41/7.1.3/0671 | Cipla Medpro (Pty) Ltd | active | 1 Jan 1900 |
| CIPLASYL 8 | 41/7.1.3/0672 | Cipla Medpro (Pty) Ltd | active | 1 Jan 1900 |
| CIPLA PERINDOPRIL 4 mg | 41/7.1.3/0674 | Cipla Medpro (Pty) Ltd | active | 1 Jan 1900 |
Perindopril Erbumine — SAHPRA Registration Details
SAHPRA (South Africa) has 5 registered products containing Perindopril Erbumine, of which 3 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Perindopril Erbumine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.